SCHEMBL25494759

SCHEMBL25494759

CC(C)CCOCCBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL42956 0.85 ALDH1A1 (0.48) —
SCHEMBL11584374 0.82 ALDH1A1 (0.34) —
SCHEMBL11736517 0.82 ALDH1A1 (0.34) —
SCHEMBL17401248 0.82 ALDH1A1 (0.46) —
SCHEMBL9452585 0.82 ALDH1A1 (0.46) —
Magnesium SCHEMBL8463764 0.82 ALDH1A1 (0.46) —
SCHEMBL9945700 0.82 ALDH1A1 (0.46) —
SCHEMBL9945705 0.82 ALDH1A1 (0.46) —
SCHEMBL8731954 0.82 ALDH1A1 (0.46) —
Methane SCHEMBL887751 0.82 ALDH1A1 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230279426-A1 MODIFIED VIRAL COMPOSITIONS FOR VIRAL TRANSDUCTION LYCIA THERAPEUTICS, INC. 2023-09-07 — — US disclosed
US-20230226214-A1 BIFUNCTIONAL BRIDGING COMPOSITIONS FOR VIRAL TRANSDUCTION LYCIA THERAPEUTICS, INC. 2023-07-20 — — US disclosed
US-20230158155-A1 Cell Surface Receptor Binding Compounds and Conjugates LYCIA THERAPEUTICS, INC. 2023-05-25 — — US disclosed
Send feedback